SABBY MANAGEMENT, LLC - Q2 2018 holdings

$647 Million is the total value of SABBY MANAGEMENT, LLC's 138 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 83.9% .

 Value Shares↓ Weighting
SellSPDR S&P 500put$65,107,000
-87.5%
2,400
-87.8%
10.06%
-67.6%
SellBIOGEN INCput$62,891,000
-35.7%
2,451
-40.8%
9.72%
+66.4%
SellISHARES RUSSELL 2000call$61,414,000
-19.1%
3,750
-25.0%
9.49%
+109.4%
NewSPDR S&P 500call$54,229,0001,999
+100.0%
8.38%
BIIB SellBIOGEN INC$44,146,000
-55.9%
152,102
-58.4%
6.82%
+14.1%
NewNOVO NORDISK A/Sput$28,691,0006,221
+100.0%
4.43%
SellSAREPTA THERAPEUTICS INCcall$27,983,000
-19.1%
2,117
-54.6%
4.32%
+109.5%
SellESPERION THERAPEUTICS INCput$27,386,000
-68.7%
6,988
-42.3%
4.23%
-19.1%
NVO NewNOVO NORDISK A/Sadr$19,802,000429,355
+100.0%
3.06%
NewNOVO NORDISK A/Scall$18,319,0003,972
+100.0%
2.83%
BuyNEKTAR THERAPEUTICSput$14,537,000
+144.3%
2,977
+431.6%
2.25%
+532.7%
NewSPDR S&P BIOTECHcall$13,603,0001,429
+100.0%
2.10%
ODT SellODONATE THERAPEUTICS INC$12,775,000
-58.9%
578,599
-60.6%
1.97%
+6.3%
SellSAREPTA THERAPEUTICS INCput$12,002,000
-8.8%
908
-48.9%
1.85%
+136.2%
NKTR BuyNEKTAR THERAPEUTICS$11,813,000
-5.5%
241,922
+105.6%
1.82%
+144.6%
SellASTRAZENECA PLCput$11,815,000
-79.8%
3,365
-79.9%
1.82%
-47.8%
SellASTRAZENECA PLCcall$9,589,000
-90.6%
2,731
-90.7%
1.48%
-75.8%
XERS NewXERIS PARMACEUTICALS INC$8,497,000447,686
+100.0%
1.31%
UMRX SellUNUM THERAPEUTICS INC$8,342,000
-32.1%
581,303
-47.5%
1.29%
+75.6%
SellZOGENIX INCcall$7,616,000
-76.6%
1,723
-78.8%
1.18%
-39.4%
ESPR BuyESPERION THERAPEUTICS INC$5,828,000
+114.1%
148,704
+295.0%
0.90%
+455.6%
SellSANGAMO THERAPEUTICS INCput$5,027,000
-60.9%
3,540
-47.7%
0.78%
+1.2%
SellSPDR S&P BIOTECHput$4,760,000
-75.8%
500
-77.7%
0.74%
-37.4%
SellSPARK THERAPEUTICS INCcall$4,527,000
-56.1%
547
-64.7%
0.70%
+13.5%
VBLT NewVASCULAR BIOGENICS LTD$4,084,0001,856,169
+100.0%
0.63%
BuyINSMED INCput$3,928,000
+60.6%
1,661
+52.9%
0.61%
+315.8%
SellGLOBAL BLOOD THERAPEUTICS INCcall$3,779,000
-48.4%
836
-44.9%
0.58%
+33.6%
BCLI BuyBRAINSTORM CELL THERAPEUTICS INC$3,626,000
+2490.0%
929,725
+1982.4%
0.56%
+6900.0%
OPHT NewOPHTHOTECH CORP$3,577,0001,310,078
+100.0%
0.55%
SSKN BuySTRATA SKIN SCIENCES INC$3,449,000
+368.6%
1,682,279
+166.4%
0.53%
+1111.4%
SellAMARIN CORPORATION PLCcall$3,308,000
-33.9%
10,707
-35.6%
0.51%
+70.9%
SellNEKTAR THERAPEUTICScall$3,193,000
-79.3%
654
-54.9%
0.49%
-46.4%
GNPX NewGENPREX INC.$3,174,000414,250
+100.0%
0.49%
ONS SellONCOBIOLOGICS INC$3,120,000
-16.8%
3,692,737
-12.4%
0.48%
+115.2%
INCY SellINCYTE CORP$2,775,000
-79.7%
41,419
-74.7%
0.43%
-47.3%
GLMD NewGALMED PHARMACEUTICALS LTD$2,763,000232,224
+100.0%
0.43%
SellAVEO PHARMACEUTICALS INCcall$2,760,000
-44.5%
12,214
-28.7%
0.43%
+43.4%
SellINCYTE CORPput$2,720,000
-87.4%
406
-84.3%
0.42%
-67.4%
AZN NewASTRAZENECA PLCadr$2,404,00068,464
+100.0%
0.37%
SGMO SellSANGAMO THERAPEUTICS INC$2,389,000
-55.8%
168,239
-40.8%
0.37%
+14.6%
NewFIBROGEN INCput$2,285,000365
+100.0%
0.35%
SellAMICUS THERAPEUTICS INCput$2,243,000
-25.4%
1,436
-28.2%
0.35%
+92.8%
NewMADRIGAL PHARMACEUTICALS INCcall$2,238,00080
+100.0%
0.35%
ZSAN BuyZOSANO PHARMA$2,043,000
-13.3%
500,700
+7.1%
0.32%
+124.1%
BuyADVERUM BIOTECHNOLOGIES INCcall$1,964,000
+79.2%
3,705
+96.2%
0.30%
+366.2%
CYTR NewCYTRX CORP$1,892,0001,674,431
+100.0%
0.29%
SLNO SellSOLENO THERAPEUTICS INC$1,839,000
-44.6%
785,955
-57.2%
0.28%
+43.4%
NewTESARO INCcall$1,472,000331
+100.0%
0.23%
NewMANNKIND CORPput$1,458,0004,550
+100.0%
0.22%
SellESPERION THERAPEUTICS INCcall$1,450,000
-81.4%
370
-65.6%
0.22%
-51.8%
NOVN SellNOVAN INC$1,361,000
-57.4%
462,898
-57.5%
0.21%
+9.9%
PAVM SellPAVMED INC$1,329,000
-55.4%
1,398,850
-23.0%
0.20%
+15.2%
SellSPARK THERAPEUTICS INCput$1,324,000
-90.2%
160
-92.1%
0.20%
-74.6%
BuySANGAMO THERAPEUTICS INCcall$1,247,000
+43.3%
878
+91.7%
0.19%
+271.2%
SNSS NewSUNESIS PHARMACEUTICALS INC$1,086,000512,036
+100.0%
0.17%
NewVIKING THERAPEUTICS INCcall$1,038,0001,094
+100.0%
0.16%
MGTA NewMAGENTA THERAPEUTICS INC$1,023,00075,800
+100.0%
0.16%
EIDX NewEIDOS THERAPEUTICS INC$1,014,00049,833
+100.0%
0.16%
APTX NewAPTINYX INC$1,012,00041,857
+100.0%
0.16%
RKDA SellARCADIA BIOSCIENCES INC$1,004,000
-86.1%
121,690
-59.5%
0.16%
-64.0%
CTXR SellCITIUS PHARMACEUTICALS INC$937,000
-76.4%
407,180
-68.2%
0.14%
-38.8%
SellSYNERGY PHARMACEUTICALS INCcall$914,000
-49.6%
5,254
-47.0%
0.14%
+30.6%
BuyMARINUS PHARMACEUTICALS INCcall$896,000
+160.5%
1,268
+40.6%
0.14%
+557.1%
SellBIOGEN INCcall$871,000
-47.0%
30
-50.0%
0.14%
+37.8%
OVAS SellOVASCIENCE INC$866,000
-63.5%
954,505
-67.3%
0.13%
-5.0%
EYEN SellEYENOVIA INC$845,000
-53.5%
134,164
-31.4%
0.13%
+21.3%
CHFS BuyCHF SOLUTIONS INC$837,000
-17.0%
454,811
+26.0%
0.13%
+115.0%
IDXG SellINTERPACE DIAGNOSTICS GROUP INC$830,000
-48.9%
932,954
-49.3%
0.13%
+32.0%
APOP SellCELLECT BIOTECHNOLOGY LTDadr$798,000
-74.4%
111,540
-77.1%
0.12%
-33.9%
ATOS NewATOSSA GENETICS INC$750,000340,749
+100.0%
0.12%
KZR NewKEZAR LIFE SCIENCES INC$735,00042,507
+100.0%
0.11%
PAVMZ NewPAVMED INC*w$704,0002,128,700
+100.0%
0.11%
SellAMICUS THERAPEUTICS INCcall$697,000
-77.0%
446
-77.8%
0.11%
-40.3%
SellFUELCELL ENERGY INCput$695,000
-39.0%
5,268
-20.1%
0.11%
+57.4%
FGEN NewFIBROGEN INC$657,00010,492
+100.0%
0.10%
SellAMYRIS INCput$633,000
-83.2%
990
-82.5%
0.10%
-56.4%
HEB NewHEMISPHERX BIOPHARMA INC$620,0001,938,374
+100.0%
0.10%
FOLD SellAMICUS THERAPEUTICS INC$599,000
-69.3%
38,344
-70.5%
0.09%
-20.5%
TROV NewTROVAGENE INC$578,000750,550
+100.0%
0.09%
SellZOGENIX INCput$561,000
-89.8%
127
-90.8%
0.09%
-73.5%
RSLS NewRESHAPE LIFESCIENCES INC$542,000235,498
+100.0%
0.08%
SellDBV TECHNOLOGIES SAcall$534,000
-55.1%
277
-46.3%
0.08%
+16.9%
SellSUNESIS PHARMACEUTICALS INCcall$488,000
-35.8%
2,302
-17.6%
0.08%
+66.7%
NURO SellNEUROMETRIX INC$451,000
-77.5%
343,947
-75.8%
0.07%
-41.7%
VSAR SellVERSARTIS INC$447,000
-80.7%
220,600
-84.3%
0.07%
-50.0%
OPGN NewOPGEN INC COM NEW$431,000242,257
+100.0%
0.07%
CHEKZ NewCHECK CAP LTD*w$428,000628,846
+100.0%
0.07%
INSM SellINSMED INC$421,000
-29.8%
17,800
-33.1%
0.06%
+80.6%
MBOT SellMICROBOT MED$366,000
-78.3%
494,686
-80.2%
0.06%
-43.6%
APDN SellAPPLIED DNA SCIENCES INC$349,000
-73.3%
277,319
-69.5%
0.05%
-30.8%
SellAMARIN CORPORATION PLCput$343,000
-48.7%
1,109
-50.0%
0.05%
+32.5%
NewOPHTHOTECH CORPcall$332,0001,217
+100.0%
0.05%
AXGT NewAXOVANT SCIENCES LTD$331,000146,504
+100.0%
0.05%
RXII NewRXI PHARMACEUTICALS$325,000168,462
+100.0%
0.05%
NVIV NewINVIVO THERAPEUTICS HLDGS CORP$288,000169,661
+100.0%
0.04%
ATEC NewALPHATEC HOLDINGS INC$281,00094,216
+100.0%
0.04%
INPX BuyINPIXON$273,000
-65.4%
1,685,814
+129.7%
0.04%
-10.6%
CHEK NewCHECK CAP LTD$264,00065,139
+100.0%
0.04%
HMNY BuyHELIOS AND MATHESON ANALYTICS INC$259,000
-81.7%
834,318
+67.3%
0.04%
-52.4%
EARS SellAURIS MEDICAL HOLDING AG$206,000
-81.2%
263,625
-61.6%
0.03%
-51.5%
NewSESEN BIO INCput$196,0001,003
+100.0%
0.03%
AYTU NewAYTU BIOSCIENCE INC$186,000709,312
+100.0%
0.03%
APDNW SellAPPLIED DNA SCIENCES INC*w$186,000
-42.6%
663,878
-48.8%
0.03%
+52.6%
DRRX NewDURECT CORP$168,000107,675
+100.0%
0.03%
NSPR NewINSPIREMD INC$155,000623,521
+100.0%
0.02%
TBIO NewTRANSLATE BIO INC$152,00012,000
+100.0%
0.02%
AQXP NewAQUINOX PHARMACEUTICALS INC$146,00055,203
+100.0%
0.02%
AFMD SellAFFIMED N.V.$143,000
-90.9%
86,386
-89.8%
0.02%
-76.6%
ADVM SellADVERUM BIOTECHNOLOGIES INC$144,000
-93.8%
27,263
-93.1%
0.02%
-84.1%
CANF SellCAN FITE BIOPHARMA LTD$130,000
-96.3%
109,905
-95.5%
0.02%
-90.5%
NewAQUINOX PHARMACEUTICALS INCput$121,000456
+100.0%
0.02%
SGLBW SellSIGMA LABS*w$100,000
-64.8%
284,329
-62.2%
0.02%
-11.8%
NewDURECT CORPcall$95,000607
+100.0%
0.02%
NewAFFIMED N.V.call$90,000543
+100.0%
0.01%
GALT SellGALECTIN THERAPEUTICS INC$89,000
-93.5%
14,029
-95.1%
0.01%
-82.7%
NewAFFIMED N.V.put$75,000454
+100.0%
0.01%
YTEN NewYIELD10 BIOSCIENCE INC$67,00047,740
+100.0%
0.01%
KOOL NewCESCA THERAPEUTICS INC$61,000146,472
+100.0%
0.01%
RXIIW SellRXI PHARMACEUTICALS*w$49,000
-72.2%
196,222
-50.1%
0.01%
-27.3%
BuySOPHIRIS BIO INCput$50,000
-83.0%
1,519
+4.2%
0.01%
-55.6%
FCEL SellFUELCELL ENERGY INC$40,000
-87.3%
30,140
-83.5%
0.01%
-68.4%
NSPRZ SellINSPIREMD INC*w$36,000
-40.0%
1,982,317
-50.4%
0.01%
+50.0%
NewOPHTHOTECH CORPput$36,000133
+100.0%
0.01%
CYCC NewCYCLACEL PHARMACEUTICALS INC$36,00025,000
+100.0%
0.01%
BIOC SellBIOCEPT INC$36,000
-33.3%
177,601
-3.9%
0.01%
+100.0%
BuyPLURISTEM THERAPEUTICS INCput$35,000
+2.9%
288
+18.0%
0.01%
+150.0%
NewHELIOS AND MATHESON ANALYTICS INCcall$30,000965
+100.0%
0.01%
ONTX SellONCONOVA THERAPEUTICS$26,000
-96.1%
63,218
-92.1%
0.00%
-90.0%
SCON SellSUPERCONDUCTOR TECHNOLOGIES$21,000
-98.5%
22,748
-98.5%
0.00%
-96.4%
ROSGQ SellROSETTA GENOMICS LTD$19,000
-97.5%
941,693
-49.6%
0.00%
-93.5%
CVM NewCEL SCI CORP$15,00016,591
+100.0%
0.00%
SellHELIOS AND MATHESON ANALYTICS INCput$8,000
-99.3%
246
-94.0%
0.00%
-98.6%
ONTXW SellONCONOVA THERAPEUTICS*w$8,000
-98.0%
654,019
-50.0%
0.00%
-95.7%
NSPRW SellINSPIREMD INC*w$8,000
-77.8%
837,977
-54.0%
0.00%
-50.0%
BNTCW NewBENITEC BIOPHARMA*w$8,00075,904
+100.0%
0.00%
AQB ExitAQUABOUNTY TECHNOLOGIES INC$0-226
-100.0%
0.00%
CYTXW NewCYTORI THERAPEUTICS*w$3,000300,413
+100.0%
0.00%
EGLTQ NewEGALET CORP$1,0002,134
+100.0%
0.00%
IMUCW NewIMMUNOCELLULAR THERAPEUTICS*w$1,00074,443
+100.0%
0.00%
ExitVERSARTIS INCcall$0-400
-100.0%
0.00%
HALO ExitHALOZYME THERAPEUTICS INC$0-204
-100.0%
0.00%
ExitSELLAS LIFE SCIENCES GROUP INCcall$0-3,036
-100.0%
0.00%
IMUCW ExitIMMUNOCELLULAR THERAPEUTICScall$0-450,374
-100.0%
-0.00%
CYTXW ExitCYTORI THERAPEUTICS INCcall$0-1,041,716
-100.0%
-0.00%
BNTCW ExitBENITEC BIOPHARMA LTDcall$0-175,386
-100.0%
-0.00%
VNRX ExitVOLITIONRX LTD$0-26,334
-100.0%
-0.00%
MDGS ExitMEDIGUS LTDadr$0-47,212
-100.0%
-0.00%
PSTI ExitPLURISTEM THERAPEUTICS INC$0-55,280
-100.0%
-0.01%
CHEK ExitCHECK-CAP LTD$0-150,560
-100.0%
-0.01%
AMRN ExitAMARIN CORP PLCadr$0-40,600
-100.0%
-0.01%
ExitSOPHIRIS BIO INCcall$0-580
-100.0%
-0.01%
ExitPROTHENA CORPORATION PLCcall$0-480
-100.0%
-0.01%
ExitPTC THERAPEUTICS INCcall$0-2,950
-100.0%
-0.01%
VICL ExitVICAL INC.$0-119,664
-100.0%
-0.01%
ExitGALECTIN THERAPEUTICS INCput$0-420
-100.0%
-0.01%
ExitTRANSENTERIX INCput$0-1,456
-100.0%
-0.02%
VTGN ExitVISTAGEN THERAPEUTICS INC$0-286,972
-100.0%
-0.02%
EDAP ExitEDAP TMS SAadr$0-121,200
-100.0%
-0.02%
BPTH ExitBIO PATH HOLDINGS INC$0-170,026
-100.0%
-0.02%
ExitIMMUNOGEN INCput$0-328
-100.0%
-0.02%
ABEO ExitABEONA THERAPEUTICS INC$0-25,996
-100.0%
-0.02%
SLDB ExitSOLID BIOSCIENCES INC$0-50,000
-100.0%
-0.02%
AXSM ExitAXSOME THERAPEUTICS INC$0-162,318
-100.0%
-0.02%
ExitACCELERON PHARMA INCcall$0-110
-100.0%
-0.03%
MNKD ExitMANNKIND CORPcall$0-2,000
-100.0%
-0.03%
ExitEDAP TMS SAput$0-2,016
-100.0%
-0.03%
NSPR ExitINSPIREMD INC$0-487,588
-100.0%
-0.03%
SNOA ExitSONOMA PHARMACEUTICALS INC$0-138,400
-100.0%
-0.03%
EIGR ExitEIGER BIOPHARMACEUTICALS INC$0-64,380
-100.0%
-0.04%
XENE ExitXENON PHARMACEUTICALS INC$0-134,000
-100.0%
-0.04%
XLRN ExitACCELERON PHARMA INC$0-17,292
-100.0%
-0.04%
BIOAQ ExitBIOAMBER INC$0-15,639,774
-100.0%
-0.04%
MRK ExitMERCK & CO INC$0-13,728
-100.0%
-0.04%
SNES ExitSENESTECH INC$0-1,589,480
-100.0%
-0.05%
PRPO ExitPRECIPIO INC$0-1,528,822
-100.0%
-0.05%
NAOV ExitNANOVIBRONIX INC$0-171,582
-100.0%
-0.05%
TRXC ExitTRANSENTERIX INC$0-513,430
-100.0%
-0.05%
MNKD ExitMANNKIND CORP$0-403,816
-100.0%
-0.06%
ExitFIBROGEN INCcall$0-226
-100.0%
-0.06%
PRQR ExitPROQR THERAPEUTICS N V$0-344,320
-100.0%
-0.06%
PULM ExitPULMATRIX INC$0-2,175,014
-100.0%
-0.07%
ExitMERCK & CO INCput$0-240
-100.0%
-0.08%
ATNM ExitACTINIUM PHARMACEUTICALS INC$0-3,995,400
-100.0%
-0.09%
APRI ExitAPRICUS BIOSCIENCES INC$0-3,600,000
-100.0%
-0.09%
ExitMANNKIND CORPput$0-6,448
-100.0%
-0.09%
CLSN ExitCELSION CORP$0-739,720
-100.0%
-0.10%
GLYC ExitGLYCOMIMETICS INC$0-103,206
-100.0%
-0.10%
ExitVERTEX PHARMACEUTICALS INCcall$0-2,630
-100.0%
-0.10%
OPGN ExitOPGEN INC$0-1,042,152
-100.0%
-0.10%
PRTA ExitPROTHENA CORPORATION PLC$0-49,000
-100.0%
-0.11%
APHB ExitAMPLIPHI BIOSCIENCES CORP$0-1,663,922
-100.0%
-0.11%
ExitALKERMES PLCput$0-314
-100.0%
-0.11%
ExitACHAOGEN INCcall$0-1,426
-100.0%
-0.11%
AKBA ExitAKEBIA THERAPEUTICS INC$0-204,676
-100.0%
-0.12%
ADOM ExitADOMANI INC COM$0-1,686,814
-100.0%
-0.12%
SLS ExitSELLAS LIFE SCIENCES GROUP INC$0-618,414
-100.0%
-0.13%
ExitALEXION PHARMACEUTICALS INCput$0-192
-100.0%
-0.13%
EBIO ExitELEVEN BIOTHERAPEUTICS INC$0-2,452,234
-100.0%
-0.15%
ExitPROTHENA CORPORATION PLCput$0-862
-100.0%
-0.16%
ALNY ExitALNYLAM PHARMACEUTICALS INC$0-23,000
-100.0%
-0.16%
BMY ExitBRISTOL MYERS SQUIBB$0-46,624
-100.0%
-0.18%
ExitBRISTOL MYERS SQUIBBput$0-562
-100.0%
-0.21%
ExitACHAOGEN INCput$0-2,810
-100.0%
-0.22%
ExitACCELERON PHARMA INCput$0-1,048
-100.0%
-0.24%
ExitALNYLAM PHARMACEUTICALS INCput$0-500
-100.0%
-0.36%
ExitABBVIE INCcall$0-738
-100.0%
-0.42%
ExitALKERMES PLCcall$0-1,352
-100.0%
-0.47%
ExitALEXION PHARMACEUTICALS INCcall$0-1,186
-100.0%
-0.79%
ExitINCYTE CORPcall$0-2,280
-100.0%
-1.13%
SPY ExitSPDR S&P 500tr$0-89,000
-100.0%
-1.40%
ExitMERCK & CO INCcall$0-4,980
-100.0%
-1.62%
ExitISHARES RUSSELL 2000put$0-5,750
-100.0%
-5.21%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPDR S&P 500 ETF TRUST UNIT37Q3 202349.1%
ISHARES TR35Q3 202352.2%
SPDR S&P BIOTECHNOLOGY32Q3 202212.8%
AMARIN CORP PLC30Q4 20212.0%
BIOGEN INC24Q1 202126.2%
SAREPTA THERAPEUTICS INC24Q3 20204.6%
BIOGEN INC23Q1 202113.7%
SAREPTA THERAPEUTICS INC22Q3 20206.2%
BRAINSTORM CELL THERAPEUTICS INC21Q3 20231.6%
VERTEX PHARMACEUTICALS INC20Q1 201812.6%

View SABBY MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
SABBY MANAGEMENT, LLC Q2 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AGM GROUP HOLDINGS, INC.January 10, 2023627,9362.6%
Bit Digital, IncJanuary 10, 20233,166,9173.8%
Cingulate Inc.January 10, 2023105.0%
Context Therapeutics Inc.January 10, 2023796,7065.0%
HeartBeam, Inc.January 10, 2023271,7883.4%
PharmaCyte Biotech, Inc.January 10, 2023934,4565.0%
Rebus Holdings, Inc.Sold outJanuary 10, 202300.0%
TANTECH HOLDINGS LTDJanuary 10, 202341,5000.6%
Quanergy Systems, Inc.January 04, 2023936,9055.8%
TuanChe LtdJanuary 04, 20232,384,71310.0%

View SABBY MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-03
SC 13G2024-01-03
SC 13G2024-01-03
SC 13G2024-01-03

View SABBY MANAGEMENT, LLC's complete filings history.

Compare quarters

Export SABBY MANAGEMENT, LLC's holdings